Liraglutide Patents

Given below is the list of patents protecting Liraglutide, along with the drug name that holds that patent and the company name owning that drug.

A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Liraglutide's patents.

Latest Legal Activities on Liraglutide's Patents

Given below is the list recent legal activities going on the following patents of Liraglutide.

Activity	Date	Patent Number
Critical Events for all Patents
Payment of Maintenance Fee, 8th Year, Large Entity	17 Feb, 2022	US8846618
Payment of Maintenance Fee, 4th Year, Large Entity	21 Oct, 2021	US9968659
Payment of Maintenance Fee, 12th Year, Large Entity	18 Oct, 2018	US7235627
Patent Issue Date Used in PTA Calculation Critical	15 May, 2018	US9968659
Recordation of Patent Grant Mailed Critical	15 May, 2018	US9968659
Email Notification Critical	26 Apr, 2018	US9968659
Issue Notification Mailed Critical	25 Apr, 2018	US9968659
Filing Receipt - Updated	13 Apr, 2018	US9968659
Dispatch to FDC	13 Apr, 2018	US9968659
Email Notification Critical	13 Apr, 2018	US9968659

Liraglutide's Family Patents

Full family tree

Explore Our Curated Drug Screens